The CHIPTS Combination Prevention (CP) Core promotes development and evaluation of interventions that integrate evidence-based behavioral, biomedical, technological and structural components to reduce HIV incidence and to optimize each step of the HIV care and prevention continua. In response to strategic planning and anticipation of the medicalization of HIV prevention, the CP Core focuses its resources on guiding efforts that address persistent gaps in access and adherence to care and prevention in key populations, including men who have sex with men of color, African American women, transgender individuals, youth, homeless, and incarcerated individuals. Within these key populations, we further target those with comorbidities of substance use and mental health disorders and other factors that interfere with access and adherence to antiretroviral therapy (ART). While efforts to produce measurable outcomes (e.g., viral suppression, reduction in incidence) to HIV prevention have shown remarkable success using ART, the research was conducted on populations compliant with medications. Yet the disorganizing effects in key populations of comorbid substance use and mental health disorders contribute to ?leaks? in the HIV prevention and care continua. Its three specific aims are: (1) SCIENCE: To lead the science agenda on combining behavioral, biomedical, technological and structural interventions to optimize HIV care and HIV prevention outcomes, with a focus on those with mental health and/or substance use disorders, domestically and globally; to lead in scientific research networks (e.g., HPTN, ACTG); (2) NETWORKING: To convene activities that present best practices for dissemination and scale-up of behavioral, biomedical, technological, and structural interventions; to promote science development by engaging investigators and community stakeholders; (3) CAPACITY BUILDING: To build capacity within affected communities, key stakeholders, and service organizations through community education and workforce training; to mentor emerging scientists and faculty on combination prevention approaches; to facilitate linkages between community members interested in HIV therapeutic or prevention research with ongoing research opportunities. This coordinated agenda of science, networking and capacity building will generate vanguard information and expertise that will guide efforts towards HIV eradication in both the general population and in key populations. The CP Core team is led by Director Cathy Reback, PhD, Co-Director Raphael Landovitz MD, MSc, and Associate Director Danielle Harris, MPH. Core services include: advise on research on combination HIV prevention; provide guidance on study of substance use and mental health in the context of HIV prevention; provide peer review; translate domestic HIV prevention strategies for use in foreign settings and back; advise and train cultural competence, especially in key populations with comorbid conditions; conduct workforce training; mentor emerging academicians.

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Center Core Grants (P30)
Project #
5P30MH058107-25
Application #
10090648
Study Section
Special Emphasis Panel (ZMH1)
Project Start
1997-09-30
Project End
2022-01-31
Budget Start
2021-02-01
Budget End
2022-01-31
Support Year
25
Fiscal Year
2021
Total Cost
Indirect Cost
Name
University of California Los Angeles
Department
Type
DUNS #
092530369
City
Los Angeles
State
CA
Country
United States
Zip Code
90095
Li, Michael J; Okafor, Chukwuemeka N; Gorbach, Pamina M et al. (2018) Intersecting burdens: Homophobic victimization, unstable housing, and methamphetamine use in a cohort of men of color who have sex with men. Drug Alcohol Depend 192:179-185
Ojikutu, Bisola O; Bogart, Laura M; Higgins-Biddle, Molly et al. (2018) Facilitators and Barriers to Pre-Exposure Prophylaxis (PrEP) Use Among Black Individuals in the United States: Results from the National Survey on HIV in the Black Community (NSHBC). AIDS Behav 22:3576-3587
Reback, Cathy J; Fletcher, Jesse B (2018) Elevated HIV and STI Prevalence and Incidence Among Methamphetamine-Using Men Who Have Sex With Men in Los Angeles County. AIDS Educ Prev 30:350-356
Kojima, Noah; Klausner, Jeffrey D (2018) An Update on the Global Epidemiology of Syphilis. Curr Epidemiol Rep 5:24-38
Panagiotoglou, D; Olding, M; Enns, B et al. (2018) Building the Case for Localized Approaches to HIV: Structural Conditions and Health System Capacity to Address the HIV/AIDS Epidemic in Six US Cities. AIDS Behav 22:3071-3082
Pines, Heather A; Semple, Shirley J; Strathdee, Steffanie A et al. (2018) Vaginal washing and lubrication among female sex workers in the Mexico-US border region: implications for the development of vaginal PrEP for HIV prevention. BMC Public Health 18:1009
Montgomery, Tiffany M; Mays, Vickie M; Heilemann, MarySue V et al. (2018) Acceptability and Feasibility of a Sexual Health Intervention for Young Adult Black Women. J Obstet Gynecol Neonatal Nurs 47:862-873
Javanbakht, Marjan; Westmoreland, Drew; Gorbach, Pamina (2018) Factors Associated With Pharyngeal Gonorrhea in Young People: Implications for Prevention. Sex Transm Dis 45:588-593
Lan, Chiao-Wen; Lin, Chunqing; Thanh, Duong Cong et al. (2018) Drug-related stigma and access to care among people who inject drugs in Vietnam. Drug Alcohol Rev 37:333-339
Li, Li; Hien, Nguyen Tran; Liang, Li-Jung et al. (2018) Efficacy of Communication Training of Community Health Workers on Service Delivery to People Who Inject Drugs in Vietnam: A Clustered Randomized Trial. Am J Public Health 108:791-798

Showing the most recent 10 out of 715 publications